DNA Vaccine Mediated by Rambutan-Like Mesoporous Silica Nanoparticles

  • Hao Song
  • , Yannan Yang*
  • , Jie Tang
  • , Zhengying Gu
  • , Yue Wang
  • , Min Zhang
  • , Chengzhong Yu
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

24 Scopus citations

Abstract

The development of safe and effective DNA vaccines is of great significance for treating various diseases. Mesoporous silica nanoparticles (MSNs) have been widely employed either for gene delivery or as adjuvants to amplify the immune responses, but rarely reported in DNA vaccines. In this study, the first report of MSNs-based DNA vaccine by using rambutan-like MSNs as both gene vector and adjuvant is presented. The high antigen expression and enhanced dendritic cell maturation generated by the MSNs-based DNA vaccine lead to superior immune response. Boosted antigen-specific IgG antibody, enhanced cytokine production of IFN-γ, and amplified CD8+ T cells are observed for mice treated with MSNs-based vaccines. This study showcases a powerful DNA vaccine platform with outstanding immune responses, which provides useful guidance for the design of effective nanomaterial-based vaccines.

Original languageEnglish
Article number1900154
JournalAdvanced Therapeutics
Volume3
Issue number1
DOIs
StatePublished - 1 Jan 2020

Keywords

  • DNA vaccine
  • adjuvant
  • gene delivery
  • mesoporous silica nanoparticles

Fingerprint

Dive into the research topics of 'DNA Vaccine Mediated by Rambutan-Like Mesoporous Silica Nanoparticles'. Together they form a unique fingerprint.

Cite this